SNGX
Soligenix Inc.
NASDAQ: SNGX · HEALTHCARE · BIOTECHNOLOGY
$0.35
+2.07% today
Updated 2026-04-30
Market cap
$4.34M
P/E ratio
—
P/S ratio
9.78x
EPS (TTM)
$-2.14
Dividend yield
—
52W range
$0 – $6
Volume
0.6M
Soligenix Inc. (SNGX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |